Search alternatives:
significant complication » significant implications (Expand Search), significant application (Expand Search), significant applications (Expand Search)
complication drives » complication rates (Expand Search), complication profiles (Expand Search), complication rate (Expand Search)
lower decrease » linear decrease (Expand Search), larger decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant complication » significant implications (Expand Search), significant application (Expand Search), significant applications (Expand Search)
complication drives » complication rates (Expand Search), complication profiles (Expand Search), complication rate (Expand Search)
lower decrease » linear decrease (Expand Search), larger decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
141
Longer <i>L</i><sub><i>u</i></sub> significantly decreases and delays the peak of the sound-evoked CAPs of SGN fibers.
Published 2021“…(B) Comparison of CAP measures of each population relative to normal <i>L</i><sub><i>u</i></sub> (<i>L</i><sub><i>u</i></sub> = 10 μm) at 70 dB SPL. Latencies were significantly higher for populations with <i>L</i><sub><i>u</i></sub>>10 μm and peaks were significantly lower for populations with <i>L</i><sub><i>u</i></sub>>11 μm. …”
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
Image_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.tif
Published 2021“…By multiple regression model, ΔSU was identified to be a significant determinant variable of decrease in VFA (beta, 0.302; p = 0.001).…”
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx
Published 2021“…By multiple regression model, ΔSU was identified to be a significant determinant variable of decrease in VFA (beta, 0.302; p = 0.001).…”
-
159
Early IOP lowering response following injection with ssAAV2-STC-1-FLAG.
Published 2022“…After an initial, non-significant decrease in IOP in both ssAAV2-STC-1-FLAG treated mice and ssAAV2-GFP control mice at day 1, and a return to baseline with ssAAV2-GFP by day 2, significant IOP lowering was seen following treatment with ssAAV2-STC-1-FLAG starting at day 2. …”
-
160